Research & Analysis
Many antibiotics prescribed in the United States are unnecessary or inappropriate. Improved antibiotic stewardship is needed, not only to curb the threat of antibiotic resistance but also to avoid exposing patients to unnecessary risks. Read More
International momentum to address the threat of antibiotic resistance continues to build, as evidenced by the joint declaration issued today at the World Economic Forum in Davos, Switzerland. The statement calls for renewed cooperation among governments and industry to create sustainable markets for antibiotics and for revitalization of the necessary basic scientific research and development... Read More
An approval pathway for limited-population antibacterial drugs (LPAD) would help advance the development of new antibiotics for seriously ill patients with unmet medical needs. The following Q & A provides more detail on LPAD and its benefits. Read More
Support our Work
Invest with Pew to combat antibiotic resistance.